LifeTech Scientific (SEHK:1302) - Aktienkurs, Nachrichten und Analyse

1302 Aktienübersicht

LifeTech Scientific Corporation, eine Investment-Holding, entwickelt, produziert und vertreibt weltweit interventionelle medizinische Geräte für kardiovaskuläre und periphere Gefäßkrankheiten und -störungen.

Über das Unternehmen

1302 grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	1/6
Künftiges Wachstum	4/6
Vergangene Leistung	1/6
Finanzielle Gesundheit	6/6
Dividenden	0/6

Belohnungen

Prognostiziertes Gewinnwachstum 20.55% pro Jahr

Risikoanalyse

Signifikante Insiderverkäufe in den letzten 3 Monaten

Große einmalige Posten, die sich auf die Finanzergebnisse auswirken

LifeTech Scientific Corporation Wettbewerber

LEPU ScienTech Medical Technology (Shanghai)

SEHK:2291

HK$6.6b

Beijing Chunlizhengda Medical Instruments

SEHK:1858

HK$4.9b

Angelalign Technology

SEHK:6699

HK$10.1b

AK Medical Holdings

SEHK:1789

HK$4.9b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für LifeTech Scientific
Historische Aktienkurse
Aktueller Aktienkurs	HK$1.49
52-Wochen-Hoch	HK$3.02
52-Wochen-Tief	HK$1.34
Beta	0.73
11 Monat Veränderung	-10.78%
3 Monate Veränderung	-8.59%
1 Jahr Veränderung	-47.16%
33 Jahre Veränderung	-69.15%
5 Jahre Veränderung	5.67%
Veränderung seit IPO	496.00%

Aktuelle Nachrichten und Updates

LifeTech Scientific's (HKG:1302) Soft Earnings Are Actually Better Than They Appear

Apr 25

What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You

Dec 25

Recent updates

LifeTech Scientific's (HKG:1302) Soft Earnings Are Actually Better Than They Appear

Apr 25

What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You

Dec 25

Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled

Nov 28

At HK$2.37, Is LifeTech Scientific Corporation (HKG:1302) Worth Looking At Closely?

Nov 03

Here's What To Make Of LifeTech Scientific's (HKG:1302) Decelerating Rates Of Return

Oct 14

There's Been No Shortage Of Growth Recently For LifeTech Scientific's (HKG:1302) Returns On Capital

Jul 15

Does LifeTech Scientific (HKG:1302) Deserve A Spot On Your Watchlist?

Jun 30

A Look At The Fair Value Of LifeTech Scientific Corporation (HKG:1302)

Jun 15

Returns At LifeTech Scientific (HKG:1302) Are On The Way Up

Apr 03

Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock

Mar 15

Is LifeTech Scientific Corporation (HKG:1302) Potentially Undervalued?

Jan 22

Some Investors May Be Worried About LifeTech Scientific's (HKG:1302) Returns On Capital

Dec 19

Here's Why I Think LifeTech Scientific (HKG:1302) Might Deserve Your Attention Today

Dec 06

Is LifeTech Scientific (HKG:1302) A Risky Investment?

Nov 20

An Intrinsic Calculation For LifeTech Scientific Corporation (HKG:1302) Suggests It's 34% Undervalued

Oct 12

The Returns On Capital At LifeTech Scientific (HKG:1302) Don't Inspire Confidence

Sep 13

Should You Be Adding LifeTech Scientific (HKG:1302) To Your Watchlist Today?

Aug 28

What Is LifeTech Scientific Corporation's (HKG:1302) Share Price Doing?

Aug 13

LifeTech Scientific's (HKG:1302) Returns On Capital Not Reflecting Well On The Business

Jun 08

Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock

May 26

Should You Investigate LifeTech Scientific Corporation (HKG:1302) At HK$4.14?

May 11

LifeTech Scientific (HKG:1302) Could Easily Take On More Debt

Mar 31

Shareholders Are Thrilled That The LifeTech Scientific (HKG:1302) Share Price Increased 274%

Feb 21

Do Insiders Own Lots Of Shares In LifeTech Scientific Corporation (HKG:1302)?

Jan 26

Does LifeTech Scientific's (HKG:1302) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 13

Are Strong Financial Prospects The Force That Is Driving The Momentum In LifeTech Scientific Corporation's HKG:1302) Stock?

Nov 25

Aktionärsrenditen

	1302	HK Medical Equipment	HK Markt
7D	7.2%	0.7%	2.3%
1Y	-47.2%	-47.9%	4.8%

Rendite im Vergleich zur Industrie: 1302 wie die Branche Hong Kong Medical Equipment , die im vergangenen Jahr eine Rendite von -47.9 erzielte.

Rendite vs. Markt: 1302 hinter dem Markt Hong Kong zurück, der im vergangenen Jahr eine Rendite von -1.8 erzielte.

Preisvolatilität

Is 1302's price volatile compared to industry and market?
1302 volatility
1302 Average Weekly Movement	6.0%
Medical Equipment Industry Average Movement	6.9%
Market Average Movement	6.9%
10% most volatile stocks in HK Market	14.9%
10% least volatile stocks in HK Market	3.7%

Stabiler Aktienkurs: 1302Der Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.

Volatilität im Zeitverlauf: 1302Die wöchentliche Volatilität (5%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1999	1,448	Yuehui Xie	www.lifetechmed.com

LifeTech Scientific Corporation, eine Investment-Holding, entwickelt, produziert und handelt weltweit mit interventionellen medizinischen Geräten für kardiovaskuläre und periphere vaskuläre Erkrankungen und Störungen. Das Unternehmen ist in den Geschäftsbereichen Strukturelle Herzkrankheiten, Periphere Gefäßkrankheiten und Herzschrittmacher und Elektrophysiologie tätig. Zu den Produkten des Unternehmens gehören LAmbre-Systeme zum Verschluss des linken Vorhofohrs sowie CeraFlex-, Cera-, HeartR- und Konar-MF-VSD-Okkluder; Ankura-Systeme für thorakale Aortenaneurysmen und abdominale Aortenaneurysmen; Futhrough-Systeme für endovaskuläre Nadeln; Einführungssysteme wie Fustar steerable und SteerEase, Zoetrack-Führungsdrähte, Aegisy-Vena-Cava-Filter, Cera-Gefäßstopfensysteme, AcuMark-Dimensionierungsballons, implantierbare Herzschrittmacher von HearTone und SeQure-Schlingensysteme sowie Herzschrittmacher.

LifeTech Scientific Corporation's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von LifeTech Scientific im Vergleich zum Marktanteil des Unternehmens?
1302 grundlegende Statistiken
Marktanteil	HK$6.90b
Gewinn(TTM)	HK$282.75m
Umsatz(TTM)	HK$1.36b

24.4x

Kurs-Gewinn-Verhältnis

5.1x

Kurs-Umsatz-Verhältnis

Ist 1302 zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
1302 Gewinn- und Verlustrechnung (TTM)
Einnahmen	CN¥1.27b
Kosten der Einnahmen	CN¥271.54m
Bruttogewinn	CN¥995.64m
Sonstige Ausgaben	CN¥732.40m
Umsatz	CN¥263.24m

Zuletzt gemeldete Gewinne

Dec 31, 2023

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	0.057
Bruttomarge	78.57%
Nettogewinnspanne	20.77%
Schulden/Eigenkapital-Verhältnis	0%

Wie hat sich 1302 auf lange Sicht entwickelt?

Historische Performance und Vergleiche

1302 Aktienübersicht

Belohnungen

Risikoanalyse

LifeTech Scientific Corporation Wettbewerber

SEHK:2291

HK$6.6b

SEHK:1858

HK$4.9b

SEHK:6699

HK$10.1b

SEHK:1789

HK$4.9b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System

LifeTech Scientific's (HKG:1302) Soft Earnings Are Actually Better Than They Appear

LifeTech Scientific Corporation, Annual General Meeting, May 27, 2024

Full year 2023 earnings released: EPS: CN¥0.06 (vs CN¥0.077 in FY 2022)

LifeTech Scientific Corporation to Report Fiscal Year 2023 Results on Mar 28, 2024

What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You

Recent updates

LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System

LifeTech Scientific's (HKG:1302) Soft Earnings Are Actually Better Than They Appear

LifeTech Scientific Corporation, Annual General Meeting, May 27, 2024

Full year 2023 earnings released: EPS: CN¥0.06 (vs CN¥0.077 in FY 2022)

LifeTech Scientific Corporation to Report Fiscal Year 2023 Results on Mar 28, 2024

What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You

Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled

At HK$2.37, Is LifeTech Scientific Corporation (HKG:1302) Worth Looking At Closely?

First half 2023 earnings released: EPS: CN¥0.049 (vs CN¥0.05 in 1H 2022)

Epione Surgical Navigation System Obtained Official Registration Approval by the China NMPA

Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)

LifeTech Scientific Corporation to Report First Half, 2023 Results on Aug 30, 2023

Is There Now An Opportunity In LifeTech Scientific Corporation (HKG:1302)?

Lifetech Scientific Corporation Announces Enrollment in the Phase Iii Clinical Study of Ibs®? Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed

Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)

Full year 2022 earnings released: EPS: CN¥0.077 (vs CN¥0.068 in FY 2021)

Investor sentiment improved over the past week

LifeTech Scientific Corporation Announces Enrollment in the China Randomized Controlled Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed

Insufficient new directors

Here's What To Make Of LifeTech Scientific's (HKG:1302) Decelerating Rates Of Return

LifeTech Scientific Corporation Announces FDA Approval Investigator-Initiated Pre-Market Clinical Trial of Lambre Plus Laa Closure System Obtained Medical Insurance Coverage in the US

First half 2022 earnings released: EPS: CN¥0.05 (vs CN¥0.047 in 1H 2021)

LifeTech Scientific Corporation to Report Q2, 2022 Results on Aug 30, 2022

There's Been No Shortage Of Growth Recently For LifeTech Scientific's (HKG:1302) Returns On Capital

Does LifeTech Scientific (HKG:1302) Deserve A Spot On Your Watchlist?

A Look At The Fair Value Of LifeTech Scientific Corporation (HKG:1302)

Insufficient new directors

Returns At LifeTech Scientific (HKG:1302) Are On The Way Up

Full year 2021 earnings: EPS and revenues miss analyst expectations

LifeTech Scientific Corporation, Annual General Meeting, May 27, 2022

Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock

Is LifeTech Scientific Corporation (HKG:1302) Potentially Undervalued?

Some Investors May Be Worried About LifeTech Scientific's (HKG:1302) Returns On Capital

Here's Why I Think LifeTech Scientific (HKG:1302) Might Deserve Your Attention Today

Lifetech Scientific Corporation Announces YuranosTM Abdominal Aortic Stent Graft System Obtained Registration Approval from the China NMPA

Is LifeTech Scientific (HKG:1302) A Risky Investment?

An Intrinsic Calculation For LifeTech Scientific Corporation (HKG:1302) Suggests It's 34% Undervalued

The Returns On Capital At LifeTech Scientific (HKG:1302) Don't Inspire Confidence

First half 2021 earnings released: EPS CN¥0.047 (vs CN¥0.023 in 1H 2020)

Should You Be Adding LifeTech Scientific (HKG:1302) To Your Watchlist Today?

What Is LifeTech Scientific Corporation's (HKG:1302) Share Price Doing?

Investor sentiment deteriorated over the past week

LifeTech Scientific Corporation Announces Grant of Medical Device Registration Certificate in Malaysia for Its Self-Developed Ibs Angeltm Iron Bioresorbable Scaffold System

LifeTech Scientific's (HKG:1302) Returns On Capital Not Reflecting Well On The Business

Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock

Should You Investigate LifeTech Scientific Corporation (HKG:1302) At HK$4.14?

Investor sentiment improved over the past week

Non-Executive Director has left the company

Full year 2020 earnings released: EPS CN¥0.05 (vs CN¥0.031 in FY 2019)

LifeTech Scientific (HKG:1302) Could Easily Take On More Debt

Full year 2020 earnings released: EPS CN¥0.05 (vs CN¥0.031 in FY 2019)

LifeTech Scientific Corporation to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day low: HK$3.62

Shareholders Are Thrilled That The LifeTech Scientific (HKG:1302) Share Price Increased 274%

Lifetech Scientific Corporation Announces Admission to Special Examination and Approval Procedure for Innovative Medical Devices in Respect of Artery Stent Graft System

Do Insiders Own Lots Of Shares In LifeTech Scientific Corporation (HKG:1302)?

New 90-day high: HK$5.46

New 90-day high: HK$4.43

Does LifeTech Scientific's (HKG:1302) Statutory Profit Adequately Reflect Its Underlying Profit?

Erträge & Einnahmen